Ep. 89 - Califf's Passions, RWE in China & LSP Rising
More description
2021-11-15
32 min
6 chapters
Listen elsewhere
Available Results
Generated results are saved to your library for reuse and search.
No generated results are available for this episode yet.
Transcript
No transcript is available for this episode yet.
Sign in to generate a transcript for review.
Sign in
Chapters
1. 8th Annual China Healthcare Summit: Kicks Off
2. Robert Califf's Likely Priorities at FDA
3. Bringing Down Real World Evidence Barriers In China
4. VC Focus: LSP set to get even bigger
5. Genenta Aims to Become First Italian Biotech to List in U.S.
6. Emerging Company Profile Spotlight: Alltrna, Marengo, GlycoEra, VelaVigo
8th Annual China Healthcare Summit: Kicks Off
59.0s
Robert Califf's Likely Priorities at FDA
303.0s
Bringing Down Real World Evidence Barriers In China
982.0s
VC Focus: LSP set to get even bigger
1267.0s
Genenta Aims to Become First Italian Biotech to List in U.S.
1570.0s
Emerging Company Profile Spotlight: Alltrna, Marengo, GlycoEra, VelaVigo
1666.0s